de Moel, Emma C.
Trouw, Leendert A.
Terao, Chikashi
Govind, Nimmisha
Tikly, Mohammed
El-Gabalawy, Hani
Smolik, Irene
Bang, Holger
Huizinga, Tom W. J.
Toes, René E. M.
van der Woude, Diane http://orcid.org/0000-0001-8121-5879
Article History
Received: 10 January 2023
Accepted: 8 February 2023
First Online: 8 March 2023
Declarations
:
: All patients and healthy controls supplied informed consent, and study protocols were approved by the relevant local ethics committee.For patients participating in the Leiden EAC and healthy controls, the protocol was approved by the medical ethical committee (‘Commissie Medisch Ethiek’) of the Leiden University Medical Center (B19.008).For Canadian patients and controls, the Biomedical Research Ethics Board of the University of Manitoba approved all aspects of the study (approval no. HS14453).For Japanese patients and controls, the protocol was approved by the Kyoto University Graduate School and Faculty of Medicine Ethics Committee.For South African patients and controls, the study was approved by the Human Research Ethics Committee (Medical) of the University of Witwatersrand (M10707).
: Not applicable.
: The authors declare no competing interests.